Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Treasury Shares (2021 - 2025)

Historic Treasury Shares for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $2.2 million.

  • Kiniksa Pharmaceuticals International's Treasury Shares fell 768.03% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 768.03%. This contributed to the annual value of $2.3 million for FY2024, which is 610.32% down from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Treasury Shares stood at $2.2 million for Q3 2025, which was down 768.03% from $2.3 million recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Treasury Shares high stood at $2.4 million for Q4 2023, and its period low was $495773.0 during Q2 2021.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's median Treasury Shares value was $1.9 million (recorded in 2023), while the average stood at $1.7 million.
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Treasury Shares skyrocketed by 14874.61% in 2023, and later crashed by 768.03% in 2025.
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Treasury Shares stood at $885021.0 in 2021, then surged by 96.88% to $1.7 million in 2022, then soared by 37.56% to $2.4 million in 2023, then decreased by 6.1% to $2.3 million in 2024, then dropped by 2.16% to $2.2 million in 2025.
  • Its Treasury Shares stands at $2.2 million for Q3 2025, versus $2.3 million for Q2 2025 and $2.1 million for Q1 2025.